How to buy Chinese shares in the UK

Why buy Chinese stocks?

China is home to global technology leaders including Tencent, Alibaba and BYD, as well as major financial institutions and consumer companies that have no direct equivalent on Western exchanges. The country's equity market trades at a significant valuation discount to global peers: the Hang Seng Index currently carries a price-to-earnings ratio of approximately 11, compared with around 20 for the S&P 500, which some investors view as a compelling opportunity for exposure to Asian growth. 

The most straightforward route to Chinese stocks for UK investors is through our share dealing account, which provides access to dual-listed Chinese shares on US exchanges.

The Hang Seng Index rallied sharply in early July 2026, with the Hang Seng China Enterprises Index rising as much as 3.6% in a single session as investors rotated into Chinese technology stocks that had underperformed the broader 2026 rally. Alibaba gained 11%, Tencent added 3.8% and SMIC rose 7.5% in that session, reflecting renewed appetite for Chinese equities at current valuations.

How to buy Chinese stocks from the UK

1. Via dual-listed shares on US exchanges

The most accessible route for UK investors is through Chinese companies that are dual-listed on US exchanges, primarily the NYSE and NASDAQ. Major names including Alibaba (NYSE: BABA), JD.com (NASDAQ: JD) and PDD Holdings (NASDAQ: PDD) trade in US dollars on US exchanges, and are available through our share dealing account and stocks and shares ISA in the same way as any other US-listed stock. Investors buying US-listed shares will need to complete a W8-BEN form, which confirms non-US residency and can reduce the withholding tax rate on dividends by 30%.

2. Via Hong Kong-listed shares

The Hong Kong Stock Exchange (HKEX) provides direct access to major Chinese companies including Tencent (0700.HK), Meituan (3690.HK), BYD (1211.HK) and many mainland Chinese firms listed under the 'H-share' structure. HKEX-listed stocks are generally not ISA-eligible for UK investors since HKEX is not a recognised exchange under current UK ISA rules, though companies with secondary listings on the NYSE or LSE may be accessible in an ISA through those routes.

3. Via American Depositary Receipts (ADRs)

ADRs are certificates that represent shares in a foreign company, priced in US dollars and traded on US exchanges. Several Chinese companies are available as ADRs, allowing UK investors to access the Hong Kong-listed shares of Tencent, CNOOC and others without trading on HKEX directly. ADRs simplify access but may not perfectly track the underlying Hong Kong-listed price due to currency and liquidity differences.

4. Via China ETFs and funds

For investors who want diversified Chinese exposure without selecting individual stocks, US ETFs and UCITS-compliant funds tracking Chinese or broader emerging market indices provide a practical route. Examples include the iShares Core MSCI China ETF, iShares MSCI EM UCITS ETF (which has significant China weighting) and dedicated China-focused ETFs available through our share dealing account or ISA. This is also the lowest-risk approach to Chinese market exposure for most long-term investors.

5. Via spread bets and CFDs

For shorter-term traders, spread bets and CFDs provide leveraged exposure to Chinese stock prices and the Hang Seng Index, with no ownership of the underlying shares. This allows both long and short positions, and spread bet profits are free from UK capital gains tax. Leveraged products carry significant risk and are not suitable for long-term investment, with 69% of retail investors losing money when trading spread bets and CFDs with us. Proper risk management strategies, such as stop-loss orders, should be understood and used to mitigate the high risks.

Chinese stocks to watch

The following are among the most widely watched Chinese stocks for UK investors as of July 2026. This is not a recommendation to buy or sell.

A note on smaller Chinese companies: many Chinese firms listed on AIM or other markets carry characteristics similar to penny stocks, with limited trading liquidity, higher volatility and less regulatory oversight than their large-cap counterparts. Position sizing and due diligence are particularly important when considering smaller Chinese names.

Risks of buying Chinese stocks

Chinese equities carry specific risks beyond those of standard equity investing. Regulatory risk is the most significant: Beijing's regulatory crackdowns on technology companies in 2021 wiped hundreds of billions from the market capitalisations of Tencent, Alibaba and Meituan in a matter of weeks, demonstrating how quickly policy decisions can affect investor returns. The mechanics of buying shares are broadly the same as for UK stocks, but the risk framework is materially different.

• Regulatory risk: the Chinese government can and does intervene in the business operations of listed companies, particularly in technology, education and financial services. New regulations can emerge rapidly without warning.
• Geopolitical risk: US-China trade tensions, Taiwan-related uncertainty and sanctions risk can affect Chinese company valuations quickly and unpredictably.
• Currency risk: Chinese stocks are priced in Hong Kong dollars (pegged to USD) or US dollars. GBP/USD movements affect sterling returns independently of stock performance.
• Accounting and transparency: some Chinese companies listed in the US have faced questions over accounting practices. The PCAOB (US audit regulator) has expanded oversight of Chinese company audits, but standards remain a consideration.
• Delisting risk: some Chinese ADRs have faced delisting pressure in the US due to audit compliance requirements. Holding shares in the Hong Kong-listed equivalent reduces this specific risk.
• VIE structures: many Chinese technology companies listed in the US use Variable Interest Entity structures, which give investors economic exposure rather than direct legal ownership of Chinese assets. This structure carries its own specific legal risks.

Chinese stocks FAQs